KP Energy's record shows seven straight years of clean audit opinions and unqualified internal-control reports, but the governance and accounting choices around it deserve scrutiny. Half the order book sits with a related party, revenue recognition has been a Key Audit Matter every year since FY21, and accounting policies have repeatedly flattered reported profit.
Key findings
- Half the order book sits with a related party
Major- The CFO stated in Q1 FY27 that the order book is "2.16 gigawatt, valued at over Rs. 2,250 crores" and "about 50% is related party". Shareholder-approved related-party limits with KPI Green Energy Limited and KP Green Engineering Limited escalated from ₹200 crore to ₹5,000 crore per counterparty, and public institutions voted 100% against the resolutions. No external valuation was relied upon for the approvals. - Revenue recognition has been an audit focus every year since FY21
Major- Auditors flagged revenue recognition on fixed-price EPCC contracts as a Key Audit Matter in FY21 and FY25, and unbilled revenue in FY23, FY24 and FY25. Revenue grew from ₹74.9 crore in FY20 to ₹1,797 crore in the latest period, while receivable days swung from 195 in FY24 to 40.95 in FY26. - Accounting choices have repeatedly flattered reported profit
Major- Gratuity and other employee benefits "have not been provided in the financial statements" in five years from FY2019-20 through FY2024-25. Wind plants are depreciated over 22 years and buildings over 60 years, beyond Schedule II norms, and prior-period items have surfaced in multiple years. - Borrowing authorisations have escalated while guarantees back the facilities
Major- Shareholder borrowing-power authorisations rose from ₹600 crore in FY2019-20 to ₹2,000 crore in September 2024. Working capital facilities were secured by personal guarantees of directors and family members plus a corporate guarantee from KPI Global Infrastructure Ltd. CARE Ratings revised its outlook to Negative in September 2024, then upgraded to CARE A-; Stable in November 2025. - Operating cash flow covers less than half of EBITDA over a decade
Minor- Cumulative CFO/EBITDA over 10 years is 0.46x, and FY2025 free cash flow was negative ₹96.05 crore. Dividends were ₹1.67 crore for FY2023-24, ₹4 crore for FY2024-25, and ₹6.06 crore for FY2025-26, with the FY2025-26 figure including a proposed final dividend subject to shareholder approval. The promoter subscribed to ₹28.4 crore of warrants. - Persistent litigation and tax exposure sit with zero provisions
Minor- Seven Gujarat High Court matters and one income-tax reassessment of ₹2.32 crore are disclosed as contingent liabilities with no provision made. The same six PILs/SCAs have been pending since at least FY2019-20. All IBC creditor petitions were disposed of or withdrawn. - A layered group structure with nominee-held stakes
Minor- The group comprises five subsidiaries, one associate and five SPVs, with two subsidiaries held partly through nominee shareholders. The company has repeatedly sold or reclassified stakes, including disinvesting its entire 51% stake in Evergreen Mahuva Windfarms during FY2025-26. - Seven consecutive years of clean audit opinions
Clean- Auditors issued unqualified opinions on standalone and consolidated statements every year from FY2019-20 through FY2025-26. Internal financial controls opinions were unqualified throughout, and CARO reported no fraud by the company in FY2025-26. The only recurring observation was unexecuted Right-of-Way compensation agreements at each year-end.
What to watch
- Income-tax reassessment. The AY 2019-20 proceedings under Section 147 read with Section 144B stand at ₹2.32 crore including interest, as of FY2025-26.
- Gujarat High Court matters. Six PILs/SCAs have remained pending since at least FY2019-20.
- 17th AGM resolutions. Shareholder votes on Prof. Sunil Kumar Maheshwari's appointment and remuneration, NED stock options, and auditor appointment were noticed for September 29, 2026.
- CARE Ratings action. The next rating review follows the 12-Nov-2025 reaffirmation at CARE A-; Stable on ₹513.01 crore of facilities.
- Promoter warrant conversion. Further warrants or preferential allotments to Dr. Faruk G. Patel follow the 6,88,800 shares allotted during FY2025-26.
Bottom line: This is an audited record with clean opinions and no fraud findings, but the accounting choices and governance pattern are what a reader should weigh. Revenue recognition has been an audit focus in FY21, FY23, FY24, and FY25, half the order book is related-party work, and the company's own policies have repeatedly deferred costs and stretched asset lives. The risk is not hidden, it sits in the related-party concentration, the revenue estimates, and the remuneration approvals, so read those sections of the annual report with the watch items above in mind.